Drug 1 and Drug 2 follow separate, uncoordinated pathways, often failing to reach the same target locations.
This lack of precision—combined with widespread toxicity—leads to harmful effects throughout the body and limits therapeutic success.
Conjugate Synthesis Platform
How Our New Drug Works Compared to Standard Therapy: Targeting Brain Cancer
Traditional approach
(The old way)
Drug 1
Drug 2
New conjugate approach
(The New Way)
Drug 1 +2
CBD
With our innovative conjugate technology, Drug 2 is released precisely at the site of Drug 1’s action, ensuring both are always present at the same location.
This targeted delivery dramatically reduces toxicity compared to Drug 1 and Drug 2 alone. The toxic effects are localized to the site of the cancer, sparing the rest of the body from harmful side effects.
